美股市场个股详情

GERNW GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)

添加自选
  • 1.500
  • +0.120+8.70%
延时15分钟行情收盘价 11/22 16:00 (美东)
0总市值0.00市盈率TTM

关于GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)公司

杰龙公司是一家临床阶段生物制药公司,专注于研究和开发癌症治疗药物。公司的在研药物 Imelstat 正在接受测试,用于治疗骨髓增生异常综合征,一种血液疾病,和骨髓纤维化,一种影响骨髓的罕见血癌。公司通过合作协议,里程碑,版税和许可安排获得收入。杰龙拥有该药物的各种权利。该公司的业务只有一个分部,即开发肿瘤治疗产品。

公司介绍

公司代码GERNW
公司名称GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)
上市日期1996/07/30
成立日期1990
CEODr. John A. Scarlett,M.D.
所属市场粉单
员工数量141
年结日12-31
公司地址919 East Hillsdale Boulevard,Suite 250
城市Foster City
省份加利福尼亚州
国家美国
邮编94404
电话1-650-473-7700

董事高管

  • 姓名
  • 职务
  • 年薪
  • Dr. John A. Scarlett,M.D.
  • Chairman of the Board, Chief Executive Officer and President
  • 492.41万
  • Michelle Robertson
  • Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 246.97万
  • Dr. Andrew J. Grethlein,PhD
  • Executive Vice President and Chief Operating Officer
  • 241.51万
  • Shannon T. Odam
  • Senior Vice President and Chief People Officer
  • --
  • Melissa A. Kelly Behrs
  • Executive Vice President, Business Operations and Chief Alliance Officer
  • --
  • Scott A. Samuels
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 360.87万
  • Anil Kapur
  • Executive Vice President, Corporate Strategy and Chief Commercial Officer
  • --
  • Dr. Faye Feller
  • Executive Vice President and Chief Medical Officer
  • --
  • Edward E. Koval
  • Executive Vice President and Chief Business Officer
  • --
  • Dr. Robert J. Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 35.09万
  • John F. McDonald
  • Independent Director
  • 34.84万
  • Dr. V. Bryan Lawlis, PhD
  • Independent Director
  • 36.09万
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 34.59万
  • Dr. Gaurav Aggarwal, M.D.
  • Independent Director
  • 29.08万
  • Elizabeth G. O’Farrell
  • Lead Independent Director
  • 37.55万
  • Dawn Carter Bir
  • Independent Director
  • 34.31万

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议
美股
综合热度
股票代码
最新价
涨跌幅

暂无数据